caverject impulse

Generic: alprostadil

Labeler: pharmacia & upjohn company llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name caverject impulse
Generic Name alprostadil
Labeler pharmacia & upjohn company llc
Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRACAVERNOUS
Active Ingredients

alprostadil 10 ug/.5mL

Manufacturer
Pharmacia & Upjohn Company LLC

Identifiers & Regulatory

Product NDC 0009-5181
Product ID 0009-5181_eeb7c131-8178-44e1-b266-6306dc162a9b
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA021212
Listing Expiration 2026-12-31
Marketing Start 2002-06-11

Pharmacologic Class

Established (EPC)
prostaglandin analog [epc] prostaglandin e1 agonist [epc]
Mechanism of Action
prostaglandin receptor agonists [moa]
Chemical Structure
prostaglandins [cs]
Physiologic Effect
genitourinary arterial vasodilation [pe] venous vasodilation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00095181
Hyphenated Format 0009-5181

Supplemental Identifiers

RxCUI
763470 763472 763473 763474
UNII
F5TD010360
NUI
N0000009059 N0000175454 N0000180189 N0000000106 M0017805 N0000009911

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name caverject impulse (source: ndc)
Generic Name alprostadil (source: ndc)
Application Number NDA021212 (source: ndc)
Routes
INTRACAVERNOUS
source: ndc

Resolved Composition

Strengths
  • 10 ug/.5mL
source: ndc
Packaging
  • 2 SYRINGE in 1 CARTON (0009-5181-01) / .5 mL in 1 SYRINGE (0009-5181-10)
source: ndc

Packages (1)

0009-5181-01 2 SYRINGE in 1 CARTON (0009-5181-01) / .5 mL in 1 SYRINGE (0009-5181-10)

Ingredients (1)

alprostadil (10 ug/.5mL)

Linked Drug Pages (1)

Caverject Impulse ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRACAVERNOUS"], "spl_id": "eeb7c131-8178-44e1-b266-6306dc162a9b", "openfda": {"nui": ["N0000009059", "N0000175454", "N0000180189", "N0000000106", "M0017805", "N0000009911"], "unii": ["F5TD010360"], "rxcui": ["763470", "763472", "763473", "763474"], "spl_set_id": ["4dec1dbd-c63b-4a1b-81cb-c8d29696cc40"], "pharm_class_cs": ["Prostaglandins [CS]"], "pharm_class_pe": ["Genitourinary Arterial Vasodilation [PE]", "Venous Vasodilation [PE]"], "pharm_class_epc": ["Prostaglandin Analog [EPC]", "Prostaglandin E1 Agonist [EPC]"], "pharm_class_moa": ["Prostaglandin Receptor Agonists [MoA]"], "manufacturer_name": ["Pharmacia & Upjohn Company LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 SYRINGE in 1 CARTON (0009-5181-01)  / .5 mL in 1 SYRINGE (0009-5181-10)", "package_ndc": "0009-5181-01", "marketing_start_date": "20020611"}], "brand_name": "Caverject Impulse", "product_id": "0009-5181_eeb7c131-8178-44e1-b266-6306dc162a9b", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Genitourinary Arterial Vasodilation [PE]", "Prostaglandin Analog [EPC]", "Prostaglandin E1 Agonist [EPC]", "Prostaglandin Receptor Agonists [MoA]", "Prostaglandins [CS]", "Venous Vasodilation [PE]"], "product_ndc": "0009-5181", "generic_name": "Alprostadil", "labeler_name": "Pharmacia & Upjohn Company LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Caverject Impulse", "active_ingredients": [{"name": "ALPROSTADIL", "strength": "10 ug/.5mL"}], "application_number": "NDA021212", "marketing_category": "NDA", "marketing_start_date": "20020611", "listing_expiration_date": "20261231"}